BENKOWITZ MICHAEL
SEC CIK 1673232 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS Corp | Pres, COO | 33.8K | — | $350.42M | 172 | 2021-08-05 | 2026-03-15 |
Most active insiders at UTHR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ROTHBLATT MARTINE A | COB, CEO, Dir | -$863.9K | $844.54M |
| 2 | BENKOWITZ MICHAEL | Pres AND COO | — | $226.97M |
| 3 | EDGEMOND JAMES | CFO AND Treas | — | $211.57M |
| 4 | MAHON PAUL A | EVP, GC | — | $114.08M |
| 5 | SULLIVAN LOUIS W | Dir | — | $3.05M |
| 6 | PATUSKY CHRISTOPHER | Dir | — | $2.73M |
| 7 | Thompson Tommy G | Dir | — | $2.51M |
| 8 | KURZWEIL RAY | Dir | — | $2.40M |
| 9 | CAUSEY CHRISTOPHER | Dir | — | $2.33M |
| 10 | Olian Judy D. | Dir | — | $417.0K |
Transactions 172
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-03 | 2022-12-29 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $163.30 | -5,000 | 7,353 | -40% | -$816.5K |
| D | 2023-01-03 | 2022-12-29 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | S - Sale+OE | $275.99 | -5,000 | 2,353 | -68% | -$1.38M |
| D | 2022-12-23 | 2022-12-22 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $94.96 | +8,000 | 10.4K | +340% | +$759.7K |
| D | 2022-12-23 | 2022-12-22 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $277.25 | -8,000 | 2,353 | -77% | -$2.22M |
| D | 2022-12-21 | 2022-12-20 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $94.96 | +8,000 | 10.4K | +340% | +$759.7K |
| D | 2022-12-21 | 2022-12-20 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $274.05 | -8,000 | 2,353 | -77% | -$2.19M |
| D | 2022-12-16 | 2022-12-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $275.85 | -8,000 | 2,353 | -77% | -$2.21M |
| D | 2022-12-16 | 2022-12-15 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $94.96 | +8,000 | 10.4K | +340% | +$759.7K |
| D | 2022-12-14 | 2022-12-13 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $276.43 | -8,000 | 2,353 | -77% | -$2.21M |
| D | 2022-12-14 | 2022-12-13 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $94.96 | +8,000 | 10.4K | +340% | +$759.7K |
| D | 2022-12-09 | 2022-12-08 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | D - Sale to Iss | $279.88 | -8,000 | 2,353 | -77% | -$2.24M |
| D | 2022-12-09 | 2022-12-08 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres AND COO | M - OptEx | $94.96 | +8,000 | 10.4K | +340% | +$759.7K |
| D | 2021-12-22 | 2021-12-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $205.12 | -2,400 | 2,235 | -52% | -$492.3K |
| D | 2021-12-22 | 2021-12-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $61.06 | +2,400 | 4,635 | +107% | +$146.5K |
| D | 2021-12-17 | 2021-12-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $61.06 | +4,000 | 6,235 | +179% | +$244.2K |
| D | 2021-12-17 | 2021-12-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $195.86 | -4,000 | 2,235 | -64% | -$783.4K |
| D | 2021-12-15 | 2021-12-14 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $61.06 | +4,000 | 6,235 | +179% | +$244.2K |
| D | 2021-12-15 | 2021-12-14 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $193.93 | -4,000 | 2,235 | -64% | -$775.7K |
| D | 2021-12-08 | 2021-12-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $61.06 | +4,000 | 6,235 | +179% | +$244.2K |
| D | 2021-12-08 | 2021-12-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $190.41 | -4,000 | 2,235 | -64% | -$761.6K |
| D | 2021-11-24 | 2021-11-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $201.58 | -4,000 | 2,235 | -64% | -$806.3K |
| D | 2021-11-24 | 2021-11-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $61.06 | +4,000 | 6,235 | +179% | +$244.2K |
| D | 2021-11-19 | 2021-11-18 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-11-19 | 2021-11-18 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $202.61 | -4,000 | 2,235 | -64% | -$810.4K |
| D | 2021-11-17 | 2021-11-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $203.24 | -4,000 | 2,235 | -64% | -$813.0K |
| D | 2021-11-17 | 2021-11-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-11-12 | 2021-11-11 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-11-12 | 2021-11-11 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $200.90 | -4,000 | 2,235 | -64% | -$803.6K |
| D | 2021-11-10 | 2021-11-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-11-10 | 2021-11-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $198.93 | -4,000 | 2,235 | -64% | -$795.7K |
| D | 2021-11-05 | 2021-11-04 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-11-05 | 2021-11-04 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $201.44 | -4,000 | 2,235 | -64% | -$805.8K |
| D | 2021-11-03 | 2021-11-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-11-03 | 2021-11-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $192.20 | -4,000 | 2,235 | -64% | -$768.8K |
| D | 2021-10-29 | 2021-10-28 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-10-29 | 2021-10-28 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $192.17 | -4,000 | 2,235 | -64% | -$768.7K |
| D | 2021-10-27 | 2021-10-26 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-10-27 | 2021-10-26 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $190.45 | -4,000 | 2,235 | -64% | -$761.8K |
| D | 2021-10-22 | 2021-10-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-10-22 | 2021-10-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $190.66 | -4,000 | 2,235 | -64% | -$762.6K |
| D | 2021-10-08 | 2021-10-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $195.94 | -4,000 | 2,235 | -64% | -$783.8K |
| D | 2021-10-08 | 2021-10-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-24 | 2021-09-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-24 | 2021-09-23 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $200.47 | -4,000 | 2,235 | -64% | -$801.9K |
| D | 2021-09-22 | 2021-09-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $198.83 | -4,000 | 2,235 | -64% | -$795.3K |
| D | 2021-09-22 | 2021-09-21 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-17 | 2021-09-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-17 | 2021-09-16 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $205.14 | -4,000 | 2,235 | -64% | -$820.6K |
| D | 2021-09-15 | 2021-09-14 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-15 | 2021-09-14 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $208.47 | -4,000 | 2,235 | -64% | -$833.9K |
| D | 2021-09-10 | 2021-09-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-10 | 2021-09-09 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $210.89 | -4,000 | 2,235 | -64% | -$843.6K |
| D | 2021-09-08 | 2021-09-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $207.98 | -4,000 | 2,235 | -64% | -$831.9K |
| D | 2021-09-08 | 2021-09-07 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-02 | 2021-09-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-02 | 2021-09-02 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $212.31 | -4,000 | 2,235 | -64% | -$849.2K |
| D | 2021-09-01 | 2021-08-31 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-09-01 | 2021-08-31 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $214.88 | -4,000 | 2,235 | -64% | -$859.5K |
| D | 2021-08-27 | 2021-08-26 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $205.75 | -4,000 | 2,235 | -64% | -$823.0K |
| D | 2021-08-27 | 2021-08-26 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-08-24 | 2021-08-24 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $205.55 | -4,000 | 2,235 | -64% | -$822.2K |
| D | 2021-08-24 | 2021-08-24 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-08-20 | 2021-08-19 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $201.05 | -4,000 | 2,235 | -64% | -$804.2K |
| D | 2021-08-20 | 2021-08-19 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-08-18 | 2021-08-17 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-08-18 | 2021-08-17 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $203.74 | -4,000 | 2,235 | -64% | -$815.0K |
| D | 2021-08-16 | 2021-08-12 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-08-16 | 2021-08-12 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $203.05 | -4,000 | 2,235 | -64% | -$812.2K |
| D | 2021-08-11 | 2021-08-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $204.34 | -4,000 | 2,235 | -64% | -$817.4K |
| D | 2021-08-11 | 2021-08-10 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-08-06 | 2021-08-05 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | M - OptEx | $53.83 | +4,000 | 6,235 | +179% | +$215.3K |
| D | 2021-08-06 | 2021-08-05 | UTHR | UNITED THERAPEUTICS Corp | BENKOWITZ MICHAEL | Pres, COO | D - Sale to Iss | $205.42 | -4,000 | 2,235 | -64% | -$821.7K |
Purchase Sale Sale after option exercise All abbreviations